1. Home
  2. ELUT vs KUKE Comparison

ELUT vs KUKE Comparison

Compare ELUT & KUKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELUT
  • KUKE
  • Stock Information
  • Founded
  • ELUT 2015
  • KUKE 2002
  • Country
  • ELUT United States
  • KUKE China
  • Employees
  • ELUT N/A
  • KUKE N/A
  • Industry
  • ELUT Medical Specialities
  • KUKE Other Consumer Services
  • Sector
  • ELUT Health Care
  • KUKE Real Estate
  • Exchange
  • ELUT Nasdaq
  • KUKE Nasdaq
  • Market Cap
  • ELUT 88.4M
  • KUKE 86.8M
  • IPO Year
  • ELUT 2020
  • KUKE 2021
  • Fundamental
  • Price
  • ELUT $2.09
  • KUKE $1.73
  • Analyst Decision
  • ELUT Strong Buy
  • KUKE
  • Analyst Count
  • ELUT 2
  • KUKE 0
  • Target Price
  • ELUT $8.00
  • KUKE N/A
  • AVG Volume (30 Days)
  • ELUT 29.0K
  • KUKE 31.2K
  • Earning Date
  • ELUT 08-14-2025
  • KUKE 10-15-2025
  • Dividend Yield
  • ELUT N/A
  • KUKE N/A
  • EPS Growth
  • ELUT N/A
  • KUKE N/A
  • EPS
  • ELUT N/A
  • KUKE N/A
  • Revenue
  • ELUT $23,683,000.00
  • KUKE $9,442,397.00
  • Revenue This Year
  • ELUT $20.10
  • KUKE N/A
  • Revenue Next Year
  • ELUT $85.89
  • KUKE N/A
  • P/E Ratio
  • ELUT N/A
  • KUKE N/A
  • Revenue Growth
  • ELUT N/A
  • KUKE N/A
  • 52 Week Low
  • ELUT $1.61
  • KUKE $1.45
  • 52 Week High
  • ELUT $5.12
  • KUKE $17.50
  • Technical
  • Relative Strength Index (RSI)
  • ELUT 52.40
  • KUKE 24.85
  • Support Level
  • ELUT $1.96
  • KUKE $1.65
  • Resistance Level
  • ELUT $2.30
  • KUKE $1.88
  • Average True Range (ATR)
  • ELUT 0.14
  • KUKE 0.16
  • MACD
  • ELUT 0.01
  • KUKE 0.00
  • Stochastic Oscillator
  • ELUT 45.03
  • KUKE 11.76

About ELUT Elutia Inc.

Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.

About KUKE Kuke Music Holding Limited

Kuke Music Holding Ltd provides classical music licensing, subscription, and education services in China. The company licenses its music content to online music entertainment platforms, such as Tencent Music Entertainment Group, digital music service providers, such as NetEase Cloud Music, as well as film and TV production companies, airlines, and smart hardware companies. Users can access the platform through the website, mobile app, and smart music devices.

Share on Social Networks: